Patent Number US20120121698 A1 2012-05-17
 
Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
The present invention relates to, inter alia, pharmaceutical compositions comprising EPA and one or more cardiovascular agents, and to therapeutic methods for treating various diseases and disorders using the same.
 ©Questel
FamPat family
Publication Number Type Publi.Date Links
  EP2424521 A2 2012-03-07
STG: (A2) Application published without search report
AP: 2010EP-0770320
  EP2424521 A4 2015-03-04
STG: (A4) Supplementary search report
AP: 2010EP-0770320
  EP3563842 A1 2019-11-06
STG: (A1) Application published with search report
AP: 2019EP-0156780
  EP3791880 A1 2021-03-17
STG: (A1) Application published with search report
AP: 2020EP-0175804
  EP4008327 A1 2022-06-08
STG: (A1) Application published with search report
AP: 2022EP-0152979
  US20120093922 A1 2012-04-19
STG: (A1) Application published
AP: 2010US-13124628
  US20120172432 A1 2012-07-05
STG: (A1) Application published
AP: 2012US-13418591
  US20130195972 A1 2013-08-01
STG: (A1) Application published
AP: 2013US-13758332
  US20140155455 A1 2014-06-05
STG: (A1) Application published
AP: 2014US-14175515
  US20210100764 A1 2021-04-08
STG: (A1) Application published
AP: 2020US-17127354
  US20210100765 A1 2021-04-08
STG: (A1) Application published
AP: 2020US-17127398
  US20210113509 A1 2021-04-22
STG: (A1) Application published
AP: 2020US-17127652
  US20210212974 A1 2021-07-15
STG: (A1) Application published
AP: 2021US-17208091
  US20210379002 A1 2021-12-09
STG: (A1) Application published
AP: 2021US-17393213
  US20220241234 A1 2022-08-04
STG: (A1) Application published
AP: 2022US-17725357
  US20120121698 A1 2012-05-17
STG: (A1) Application published
AP: 2010US-13266085
  US11033523 B2 2021-06-15
STG: (B2) Granted patent as second publication
AP: 2010US-13266085
  US20120302589 A1 2012-11-29
STG: (A1) Application published
AP: 2012US-13417899
  US8563608 B2 2013-10-22
STG: (B2) Granted patent as second publication
AP: 2012US-13417899
  US20130005757 A1 2013-01-03
STG: (A1) Application published
AP: 2012US-13540319
  US8618166 B2 2013-12-31
STG: (B2) Granted patent as second publication
AP: 2012US-13540319
  US20130253030 A1 2013-09-26
STG: (A1) Application published
AP: 2013US-13898447
  US20130253031 A1 2013-09-26
STG: (A1) Application published
AP: 2013US-13898457
  US8680144 B2 2014-03-25
STG: (B2) Granted patent as second publication
AP: 2013US-13898457
  US8691871 B2 2014-04-08
STG: (B2) Granted patent as second publication
AP: 2013US-13898447
  US20140154310 A1 2014-06-05
STG: (A1) Application published
AP: 2014US-14175602
  US9056088 B2 2015-06-16
STG: (B2) Granted patent as second publication
AP: 2014US-14175602
  US20150231102 A1 2015-08-20
STG: (A1) Application published
AP: 2015US-14704329
  US9855237 B2 2018-01-02
STG: (B2) Granted patent as second publication
AP: 2015US-14704329
  US20150272917 A1 2015-10-01
STG: (A1) Application published
AP: 2014US-14536161
  US10888537 B2 2021-01-12
STG: (B2) Granted patent as second publication
AP: 2014US-14536161
  US20170014366 A1 2017-01-19
STG: (A1) Application published
AP: 2016US-15273430
  US10220013 B2 2019-03-05
STG: (B2) Granted patent as second publication
AP: 2016US-15273430
  US20180042880 A1 2018-02-15
STG: (A1) Application published
AP: 2017US-15725617
  US10265287 B2 2019-04-23
STG: (B2) Granted patent as second publication
AP: 2017US-15725617
  US20190070141 A1 2019-03-07
STG: (A1) Application published
AP: 2018US-16179763
  US10940131 B2 2021-03-09
STG: (B2) Granted patent as second publication
AP: 2018US-16179763
  US20190183831 A1 2019-06-20
STG: (A1) Application published
AP: 2019US-16284543
  US10624870 B2 2020-04-21
STG: (B2) Granted patent as second publication
AP: 2019US-16284543
  US20190240182 A1 2019-08-08
STG: (A1) Application published
AP: 2019US-16389317
  US10792267 B2 2020-10-06
STG: (B2) Granted patent as second publication
AP: 2019US-16389317
  US20200121628 A1 2020-04-23
STG: (A1) Application published
AP: 2019US-16709492
  US10987331 B2 2021-04-27
STG: (B2) Granted patent as second publication
AP: 2019US-16709492
  US20210000779 A1 2021-01-07
STG: (A1) Application published
AP: 2020US-17027069
  US11154526 B2 2021-10-26
STG: (B2) Granted patent as second publication
AP: 2020US-17027069
  US20220079906 A1 2022-03-17
STG: (A1) Application published
AP: 2021US-17457126
  US20220079907 A1 2022-03-17
STG: (A1) Application published
AP: 2021US-17457160
  US11400069 B2 2022-08-02
STG: (B2) Granted patent as second publication
AP: 2021US-17457160
  US11690820 B2 2023-07-04
STG: (B2) Granted patent as second publication
AP: 2021US-17457126
PCT  WO2010/127099 A2 2010-11-04
STG: (A2) International application published with declaration under Article 17 (2) (a)
AP: 2010WO-US32948
PCT  WO2010/127099 A3 2014-03-20
STG: (A3) Later publication of ISR with revised front page
AP: 2010WO-US32948
  RU2022100434 A 2022-03-11
STG: (A) Application for invention
AP: 2022RU-0100434
  RU2011148363 A 2013-06-10
STG: (A) Application for invention
AP: 2011RU-0148363
  RU2489145 C1 2013-08-10
STG: (C1) Patent for invention
AP: 2011RU-0148363
  RU2013106526 A 2014-08-20
STG: (A) Application for invention
AP: 2013RU-0106526
  RU2624506 C2 2017-07-04
STG: (C2) Patent for invention ( 2nd publ.)
AP: 2013RU-0106526
  RU2013116807 A 2014-10-20
STG: (A) Application for invention
AP: 2013RU-0116807
  RU2648826 C2 2018-03-28
STG: (C2) Patent for invention ( 2nd publ.)
AP: 2013RU-0116807
  RU2017121277 A 2018-12-19
STG: (A) Application for invention
AP: 2017RU-0121277
  RU2017121277 A3 2020-08-10
STG: (A3) Separately published search report for application patent for invention
AP: 2017RU-0121277
  RU2746945 C2 2021-04-22
STG: (C2) Patent for invention ( 2nd publ.)
AP: 2017RU-0121277
  RU2017145265 A 2019-06-24
STG: (A) Application for invention
AP: 2017RU-0145265
  RU2017145265 A3 2021-09-17
STG: (A3) Separately published search report for application patent for invention
AP: 2017RU-0145265
  RU2779052 C2 2022-08-31
STG: (C2) Patent for invention ( 2nd publ.)
AP: 2017RU-0145265
  CN102413825 A 2012-04-11
STG: (A) Published application
AP: 2010CN-80019298
  CO6470839 A2 2012-06-29
STG: (A2) Application derived from a PCT application
AP: 2011CO-0163910
  BRPI1014405 A0 2012-12-04
STG: (A0) Application filed, as announced in the Gazette published by this office
AP: 2010BR-0014405
  BRPI1014405 A2 2016-04-05
STG: (A2) Application for a patent of invention / pipeline patent published without search report
AP: 2010BR-0014405
  IN8692/CHENP/2011 A 2013-03-22
STG: (A) Application laid open
AP: 2011IN-CN08692
  NZ595789 A 2014-05-30
STG: (A) Published application
AP: 2010NZ-0595789
  TH135803 A 2014-08-07
STG: (A) Published application
AP: 2011TH-1002845
  CN104042617 A 2014-09-17
STG: (A) Published application
AP: 2014CN-0136828
  HK1202795 A1 2015-10-09
STG: (A1) Patent application
AP: 2015HK-0102705
  NZ624963 A 2016-07-29
STG: (A) Published application
AP: 2010NZ-0624963
  CN106822080 A 2017-06-13
STG: (A) Published application
AP: 2016CN-0682334
  IN201748029696 A 2017-09-01
STG: (A) Application laid open
AP: 2017IN-48029696
  NZ720946 A 2017-09-29
STG: (A) Published application
AP: 2010NZ-0720946
  CN107233337 A 2017-10-10
STG: (A) Published application
AP: 2017CN-0273241
  NZ734905 A 2019-05-31
STG: (A) Published application
AP: 2010NZ-0734905
  NZ752610 A 2021-01-29
STG: (A) Published application
AP: 2010NZ-0752610
  NZ771180 A 2022-07-29
STG: (A) Published application
AP: 2010NZ-0771180
  MX2022009942 A 2022-09-12
STG: (A) Patent application
AP: 2022MX-0009942
  NZ789295 A 2024-02-23
STG: (A) Published application
AP: 2010NZ-0789295
  CA2759176 A1 2010-11-04
STG: (A1) Application laid open
AP: 2010CA-2759176
  CA2759176 C 2016-03-15
STG: (C) Patent (second level)
AP: 2010CA-2759176
  AU2010241567 A1 2011-11-10
STG: (A1) Open to public inspection
AP: 2010AU-0241567
  AU2010241567 B2 2013-10-31
STG: (B2) Patent proceeded by OPI
AP: 2010AU-0241567
  SG175390 A1 2011-12-29
STG: (A1) Patent Application
AP: 2011SG-0079415
  SG175390 B 2014-05-16
STG: (B) Patent Granted
AP: 2011SG-0079415
  MX2011011517 A 2012-06-19
STG: (A) Patent application
AP: 2011MX-0011517
  MX323503 B 2014-09-08
STG: (B) Granted patent/ granted utility model
AP: 2011MX-0011517
  KR10-2012-0089563 A 2012-08-13
STG: (A) Published application
AP: 2011KR-7026224
  KR10-1357438 B1 2014-02-06
STG: (B1) Patent specification
AP: 2011KR-7026224
  ZA201107623 B 2014-06-25
STG: (B) Granted Patent
AP: 2011ZA-0007623
  MY173994 A 2020-03-03
STG: (A) Granted patent / Utility Model
AP: 2011MY-0005155
  MX373783 B 2020-05-20
STG: (B) Granted patent/ granted utility model
AP: 2014MX-0010570
  MX2020004099 A 2020-07-24
STG: (A) Patent application
AP: 2020MX-0004099
  MX397393 B 2022-11-11
STG: (B) Granted patent/ granted utility model
AP: 2020MX-0004099
  MY198422 A 2023-08-29
STG: (A) Granted patent / Utility Model
AP: 2016MY-0001750
  MY205872 A 2024-11-18
STG: (A) Granted patent / Utility Model
AP: 2020MY-0005343
First Date of Grant 2013-10-22
2013-12-31
2014-03-25
2014-04-08
2015-06-16
2018-01-02
2019-03-05
2019-04-23
2020-04-21
2020-10-06
2021-01-12
2021-03-09
2021-04-27
2021-06-15
2021-10-26
2022-08-02
2023-07-04
2013-08-10
2017-07-04
2018-03-28
2021-04-22
2022-08-31
2013-10-31
2014-02-06
2014-05-16
2014-06-25
2020-03-03
2023-08-29
2024-11-18
2014-09-08
2016-03-15
2020-05-20
2022-11-11
Inventor MANKU MEHAR
ROWE JONATHAN
All applicant/assignee Amarin Corporation PLC ([IE])
Amarin Pharmaceuticals Ireland Limited ([IE])
Amarin Pharmaceuticals Ireland Limited ([IE])
Amarin Pharmaceuticals Ireland Limited ([IE])
Amarin Pharmaceuticals Ireland Limited ([IE])
AMARIN CORPORATION PLC ([IE])
AMARIN PHARMA, INC. ([US])
AMARIN PHARMACEUTICALS IRELAND LIMITED ([IE])
Amarin Pharma, Inc. ([US])
Amarin Pharmaceuticals Ireland Limited ([IE])
AMARIN PHARMACEUTICALS IRELAND LIMITED ([IE])
Amarin Pharmaceuticals Ireland Limited ([IE])
AMARIN PHARMACEUTICALS IRELAND LIMITED ([IE])
Amarin Pharmaceuticals Ireland Limited ([IE])
AMARIN PHARMACEUTICALS IRELAND LIMITED ([IE])
Amarin Pharmaceuticals Ireland Limited ([IE])
AMARIN PHARMACEUTICALS IRELAND LIMITED ([IE])
AMARIN PHARMACEUTICALS IRELAND LIMITED ([IE])
Amarin Pharmaceuticals Ireland Limited ([IE])
Amarin Pharmaceuticals Ireland Limited ([IE])
Amarin Pharmaceuticals Ireland Limited ([IE])
Amarin Pharmaceuticals Ireland Limited ([IE])
Amarin Pharmaceuticals Ireland Limited ([IE])
Amarin Pharmaceuticals Ireland Limited ([IE])
Amarin Pharmaceuticals Ireland Limited ([IE])
Amarin Pharmaceuticals Ireland Limited ([IE])
AMARIN PHARMACEUTICALS IRELAND LIMITED ([IE])
Amarin Pharmaceuticals Ireland Limited ([IE])
Amarin Pharmaceuticals Ireland Limited ([IE])
Amarin Pharmaceuticals Ireland Limited ([IE])
Amarin Pharmaceuticals Ireland Limited ([IE])
Amarin Pharmaceuticals Ireland Limited ([IE])
Amarin Pharmaceuticals Ireland Limited ([IE])
Amarin Pharmaceuticals Ireland Limited ([IE])
Amarin Pharmaceuticals Ireland Limited ([IE])
Amarin Pharmaceuticals Ireland Limited ([IE])
Amarin Pharmaceuticals Ireland Limited ([IE])
Amarin Pharmaceuticals Ireland Limited ([IE])
AMARIN PHARMA, INC. ([US])
Amarin Pharmaceuticals Ireland Limited ([IE])
Amarin Pharmaceuticals Ireland Limited ([IE])
Amarin Pharmaceuticals Ireland Limited ([IE])
Amarin Pharmaceuticals Ireland Limited ([IE])
Amarin Pharmaceuticals Ireland Limited ([IE])
Amarin Pharmaceuticals Ireland Limited ([IE])
Amarin Pharmaceuticals Ireland Limited ([IE])
Amarin Pharmaceuticals Ireland Limited ([IE])
Amarin Pharmaceuticals Ireland Limited ([IE])
Amarin Pharmaceuticals Ireland Limited ([IE])
AMARIN CORPORATION PLC ([IE])
AMARIN CORPORATION PLC ([IE])
AMARIN CORP PIEHLSI ([IE])
AMARIN CORP PIEHLSI ([IE])
AMARIN CORP PIEHLSI ([IE])
AMARIN CORP PIEHLSI ([IE])
AMARIN CORP PIEHLSI ([IE])
AMARIN CORP PIEHLSI ([IE])
AMARIN CORP PIEHLSI ([IE])
AMARIN FARMASYUTIKALZ AJRLEND LIMITED ([IE])
AMARIN FARMASYUTIKALZ AJRLEND LIMITED ([IE])
AMARIN CORP PIEHLSI ([IE])
AMARIN FARMASYUTIKALZ AJRLEND LIMITED ([IE])
AMARIN CORPORATION PLC
Amarin Corporation PLC
Amarin Pharmaceuticals Ireland Limited
AMARIN CORPORATION PLC
AMARIN CORPORATION PLC
AMARIN PHARMACEUTICALS IRELAND LIMITED ([IE])
AMARIN PHARMACEUTICALS IRELAND LIMITED ([IE])
AMARIN PHARMACEUTICALS IRELAND LIMITED
AMARIN CORPORATION PLC
AMARIN PHARMACEUTICALS IRELAND LIMITED
Amarin Pharmaceuticals Ireland Limited
Amarin Pharmaceuticals Ireland Limited
Amarin Pharmaceuticals Ireland Limited
AMARIN CORPORATION PLC
Amarin Pharmaceuticals Ireland Limited
Amarin Pharmaceuticals Ireland Limited
AMARIN PHARMACEUTICALS IE LTD ([IE])
AMARIN PHARMACEUTICALS IE LTD
AMARIN PHARMACEUTICALS IE LTD ([IE])
AMARIN CORP. PLC
AMARIN CORPORATION PLC
Amarin Corporation PLC
AMARIN CORPORATION PLC
AMARIN CORPORATION PLC ([IE])
AMARIN PHARMACEUTICALS IE LTD
AMARIN PHARMACEUTICALS IRELAND LIMITED
AMARIN CORPORATION PLC ([IE])
AMARIN CORPORATION PLC ([IE])
AMARIN CORPORATION PLC
AMARIN PHARMACEUTICALS IE LTD
AMARIN PHARMACEUTICALS IE LTD
AMARIN CORPORATION PLC ([IE])
AMARIN PHARMACEUTICALS IE LTD ([IE])
AMARIN PHARMACEUTICALS IRELAND LIMITED.*
AMARIN PHARMACEUTICALS IRELAND LIMITED* ([IE])
Priority Details 2009US-61173759 2009-04-292010CN-80019298 2010-04-292010EP-0770320 2010-04-292010NZ-0595789 2010-04-292010NZ-0624963 2010-04-292010NZ-0720946 2010-04-292010NZ-0734905 2010-04-292010NZ-0752610 2010-04-292010NZ-0771180 2010-04-292010US-13124628 2010-04-292010US-13266085 2010-04-292010US-13266085 2012-01-302010WO-US32948 2010-04-292012US-13417899 2012-03-122012US-13418591 2012-03-132012US-13540319 2012-07-022013US-13758332 2013-02-042013US-13898447 2013-05-202013US-13898457 2013-05-202014US-14175515 2014-02-072014US-14175602 2014-02-072014US-14536161 2014-11-072015US-14704329 2015-05-052016US-15273430 2016-09-222017US-15725617 2017-10-052018US-16179763 2018-11-022019EP-0156780 2010-04-292019US-16284543 2019-02-252019US-16389317 2019-04-192019US-16709492 2019-12-102020US-17027069 2020-09-212020US-17127354 2020-12-182020US-17127398 2020-12-182020US-17127652 2020-12-182021US-17208091 2021-03-222021US-17393213 2021-08-032021US-17457126 2021-12-012021US-17457160 2021-12-012022US-17725357 2022-04-20
Designated States Contracting States: AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR
Contracting States: AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR
Contracting States: AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR
Contracting States: AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR
National States: AE AG AL AM AO AT AU AZ BA BB BG BH BR BW BY BZ CA CH CL CN CO CR CU CZ DE DK DM DO DZ EC EE EG ES FI GB GD GE GH GM GT HN HR HU ID IL IN IS JP KE KG KM KN KP KR KZ LA LC LK LR LS LT LU LY MA MD ME MG MK MN MW MX MY MZ NA NG NI NO NZ OM PE PG PH PL PT RO RS RU SC SD SE SG SK SL SM ST SV SY TH TJ TM TN TR TT TZ UA UG US UZ VC VN ZA ZM ZW
ARIPO: BW GH GM KE LR LS MW MZ NA SD SL SZ TZ UG ZM ZW
EAPO: AM AZ BY KG KZ MD RU TJ TM
EPO: AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR
OAPI: BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG
   
©Questel